NFCR Writer David Perry, Author at NFCR - Page 10 of 10

NFCR Writer David Perry

“System Mistrust” Interferes With Post-Surgery Breast Cancer Treatments

BALTIMORE — A study led by a Johns Hopkins Bloomberg School of Public Health researcher indicates nearly one-third of breast cancer surgery patients went against their doctor’s advice, choosing to not begin or complete adjuvant anti-cancer therapy. The primary factor: a general mistrust of the American healthcare system. Adjuvant therapy…...

Read more

Novel Cancer Genes Discovered Via New Statistical Model

LONDON — A new statistical model developed by scientists at the Francis Crick Institute revealed 27 novel genes thought to prevent cancer from forming, in an analysis of over 2000 tumors across 12 human cancer types. The findings could help create new cancer treatments that target these genes, and open…...

Read more

Genetic Marker Can Help Focus Prostate Cancer Therapies

CLEVELAND, OH — Two studies conducted by the Cleveland Clinic revealed how a testosterone-related genetic abnormality can help predict individual patient responses to specific prostate cancer therapies. The studies, published in the October 12 issue of JAMA Oncology, suggest that men who inherit this variant would benefit from a personalized…...

Read more

New Compound Targets Metastatic Cancer Cells

​Scientists​ ​at​ ​Bar-Ilan​ ​University​ ​in​ ​Israel​ ​successfully​ ​targeted​ ​and​ ​rendered​ ​inert​ ​the​ ​enzyme that metastatic​ ​cancer​ ​cells​ ​need​ ​to​ ​survive​ ​in​ ​the​ ​body​ ​once​ ​they​ ​have​ ​left​ ​their​ ​host​ ​tumor.​ ​...

Read more